Tuesday, May 16 2023
02:15 PM – 02:30 PM PT
The Promise and Challenges of Accessing Innovative High-cost Therapies: Angelman Syndrome
Allyson Berent, DVM, DACVIM. Foundation for Angelman Syndrome Therapeutics, New York, NY
Disclosures: A. Berent: 1; Commercial Interest i.e. Company X; Ultragenyx. 1; What was received? i.e. Honorarium; Hourly pay. 1; For what role? i.e. Speaker; Consultant. 2; Commercial Interest i.e. Company X; Mahzi Therapeutics. 2; What was received? i.e. Honorarium; Salary. 2; For what role? i.e. Speaker; CDO.